肝硬化门静脉血栓患者血浆D-二聚体水平及其临床意义

doi:10.3969/j.issn.1672-5069.2012.01.009

实用肝脏病杂志 ›› 2012, Vol. 15 ›› Issue (1): 26-28.doi: 10.3969/j.issn.1672-5069.2012.01.009

肝硬化门静脉血栓患者血浆D-二聚体水平及其临床意义

姜佳丽, 展玉涛, 李莉

l00730北京市首都医科大学附属北京同仁医院消化内科

出版日期:2012-02-10 发布日期:2016-05-11
通讯作者: 展玉涛,E-mail:yutaozhan@263.com
作者简介:姜佳丽女,35岁,主治医师,硕士研究生。E-mail:jiangjl@trhos.com

The plasma D-dimer levels and their clinical significance in liver cirrhosis patients with portal vein thrombosis

Jiang Jiali, Zhan Yutao, Li Li

Department of Gastroenterology,Tongren Hospital,Capital Medical University,Beijing 100730,China

Online:2012-02-10 Published:2016-05-11

摘要/Abstract

摘要： 目的探讨肝硬化门静脉血栓（PVT）患者血浆D-二聚体水平及其临床意义。方法在77例肝硬化患者中,PVT形成患者31例,无血栓形成患者46例,依据螺旋CT检查诊断PVT,采用乳胶凝集法检测血浆D-二聚体水平。结果血栓组和无血栓组患者血浆D-二聚体水平分别为1.2±0.5 mg/l和0.6±0.4mg/l（P<0.01）;血栓组伴中重度食管静脉曲张患者血浆D-二聚体水平（1.3±0.5mg/l）显著高于轻度食管静脉曲张患者（0.9±0.5mg/l,P<0.05）;血栓形成伴消化道出血和死亡患者血浆D- 二聚体水平显著高于无出血和生存患者（P<0.01）。结论肝硬化患者血浆D-二聚体水平升高可能与PVT形成有关,并严重影响预后。

关键词: 肝硬化, 门静脉血栓, D-二聚体, 食管静脉曲张

Abstract: Objective To investigate the plasma D-dimer levels and their clinical significance in liver cirrhosis（LC） patients with portal vein thrombosis（PVT）.Methods 77 patients with LC were selected and 31 had PVT,and 46 had not.The PVT was diagnosed by CT scan and the D-dimer levels were detected.Results The plasma D-dimer levels in patients with PVT were significantly higher than that in without PVT（1.2±0.5 mg/l vs. 0.6±0.4mg/l,P<0.01）;The plasma D-dimer level in PVT patients with severe esophageal varices group（1.3±0.5mg/l） was higher significantly than that in patients with mild esophageal varices group（0.9±0.5mg/l,P<0.05）;The plasma D-dimer level in patients with gastrointestinal bleeding （1.5±0.5mg/l） was higher significantly than that in patients without gastrointestinal bleeding（0.8±0.4mg/l,P<0.01）;The plasma D-dimer level in death group（1.318±0.512mg/l）was higher significantly than in survived group（1.0±0.4mg/l,P<0.01）.Conclusion Plasma D-dimer level increases in patients with LC and might prompt the PVT formation.

Key words: Liver cirrhosis, Portal vein thrombosis, D-dimer, Esophageal varices

姜佳丽, 展玉涛, 李莉. 肝硬化门静脉血栓患者血浆D-二聚体水平及其临床意义[J]. 实用肝脏病杂志, 2012, 15(1): 26-28.

Jiang Jiali, Zhan Yutao, Li Li. The plasma D-dimer levels and their clinical significance in liver cirrhosis patients with portal vein thrombosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(1): 26-28.

参考文献

[1] Zocco MA,Enrico DS,Raimondo DC,et al. Thrombotic risk factors in patients with liver cirrhosis:Correlation with MELD scoring system and portal vein thrombosis development. J Hepatol,2009,51（4）:682-689.
[2] Okuda K,Ohnishi K,Kimura K,et al. Incidence of portal vein thrombosis in liver cirrhosis.An angiographic study in 708 patients.Gastroenterology,1985,89（2）:279-286.
[3] Janousek L,Adamec M,Oliverius M,et al. Liver transplantation in patients with portal vein thrombosis. Rozhi Chir,2011,90（2）:114-116.
[4] 中华医学会与寄生虫病学分会,肝病分会. 病毒性肝炎防治方案. 中华传染病杂志,2001,19（1）：56-62.
[5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南. 实用肝脏病杂志,2007,10（1）：4-5.
[6] 中华医学会消化内镜分会.食管静脉曲张内镜下诊断和治疗规范试行方案. 中华消化内镜杂志,2004,21（3）：149-151.
[7] Hu KQ,Yu AS,Tiyyagura L,et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol,2001,96（5）:1581.
[8] Cardiner C,Pennaneach C,Walford C,et al. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. Br J Hepatol,2005,128（6）:842-848.
[9] Amitrano L,Guardascione MA,Brancaccio V,et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol,2004,40（5）:736-741.
[10] Zhang DL,Hao JL,Yang N. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. J Gastroenterol Hepatol,2010,25（1）:116-121.
[11] 郑盛,严晓会,刘海,等. 肝硬化患者门静脉血栓形成危险因素的Logistic回归分析. 肝脏,2009,14（6）:446-448.
[12] 蒋绚,刘玉兰,金鹏华,等. 肝硬化门静脉血栓形成的临床分析.中华消化杂志,2004,24（6）:329-321.

[1]	陈帅, 杨长青. 门静脉血栓病因及危险因素研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 761-764.
[2]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[3]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[4]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[5]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[6]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[7]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[8]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[9]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[10]	王月圆, 王燕, 张丹丹. 奥曲肽辅助特利加压素治疗失代偿期肝硬化并发肝肾综合征患者疗效分析*[J]. 实用肝脏病杂志, 2019, 22(5): 684-687.
[11]	张梅, 石秀英, 李林娟, 薛亚妮. 肝源性糖尿病患者肝组织干扰素诱导蛋白-10表达变化*[J]. 实用肝脏病杂志, 2019, 22(5): 688-691.
[12]	丹珠永吉, 刘芝兰, 禄艳艳, 蒋汉梅. 内镜下序贯套扎和硬化剂治疗肝硬化并发食管胃底静脉曲张破裂出血患者疗效及对血流动力学的影响对比研究*[J]. 实用肝脏病杂志, 2019, 22(5): 692-695.
[13]	黄汉军, 鲁凤荣, 张灿. 基于Exchange血流动力学模型的MRI扫描参数诊断肝硬化临床价值分析*[J]. 实用肝脏病杂志, 2019, 22(5): 696-699.
[14]	赵芳芳, 翟永贞, 冯国和. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者疗效及安全性分析[J]. 实用肝脏病杂志, 2019, 22(5): 700-703.
[15]	陈山, 庄华帅, 邢诒喜, 吴直佳. 美罗培南治疗肝硬化并发上消化道出血患者对感染预防和再出血的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 704-707.

肝硬化门静脉血栓患者血浆D-二聚体水平及其临床意义

The plasma D-dimer levels and their clinical significance in liver cirrhosis patients with portal vein thrombosis

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价